This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsTauriga Sciences (TAUG) 주식 개요Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. 자세히 보기TAUG 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석최신 재무 보고서가 1년 이상 지났습니다.주식은 유동성이 매우 낮습니다의미 있는 시가총액이 없습니다($348)모든 위험 점검 보기TAUG Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.00000199.9% 저평가 내재 할인율Est. Revenue$PastFuture-12m313k2016201920222025202620282031Revenue US$313.5kEarnings US$46.2kAdvancedSet Fair ValueView all narrativesTauriga Sciences, Inc. 경쟁사Clever Leaves HoldingsSymbol: OTCPK:CLVRMarket cap: US$1.0BZAMSymbol: OTCPK:BZAM.FMarket cap: US$273.0Hero TechnologiesSymbol: OTCPK:HENCMarket cap: US$563.0Juva LifeSymbol: OTCPK:JUVA.FMarket cap: US$164.0가격 이력 및 성과Tauriga Sciences 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$0.00000152주 최고가US$0.0000152주 최저가US$0.000001베타01개월 변동0%3개월 변동0%1년 변동0%3년 변동-100.00%5년 변동-100.00%IPO 이후 변동-100.00%최근 뉴스 및 업데이트공시 • Aug 17Tauriga Sciences, Inc. announced delayed 10-Q filingOn 08/16/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 15Tauriga Sciences, Inc. announced delayed amended 10-K filingOn 07/14/2022, Tauriga Sciences, Inc. announced that they will be unable to file their amended 10-K by the deadline required by the SEC.공시 • Jul 01Tauriga Sciences, Inc. announced delayed annual 10-K filingOn 06/30/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 16Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/15/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Dec 22Tauriga Sciences Inc. Receives Product Endorsement from the State of AlaskaTauriga Sciences, Inc. received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska. Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program). Endorsement Applies to: Tauri-Gum™ Product Line. This Product Endorsement was issued on December 20, 2021 (AIH Registration Number: E_10119).공시 • Dec 19Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review BoardTauriga Sciences, Inc. announced that it has formally submitted its Clinical Study Protocol to the Institutional Review Board. The Company’s Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy. The purpose of this Clinical Study is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. Hyperemesis Gravidarum is also known as: Morning Sickness. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol.더 많은 업데이트 보기Recent updates공시 • Aug 17Tauriga Sciences, Inc. announced delayed 10-Q filingOn 08/16/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 15Tauriga Sciences, Inc. announced delayed amended 10-K filingOn 07/14/2022, Tauriga Sciences, Inc. announced that they will be unable to file their amended 10-K by the deadline required by the SEC.공시 • Jul 01Tauriga Sciences, Inc. announced delayed annual 10-K filingOn 06/30/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 16Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/15/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Dec 22Tauriga Sciences Inc. Receives Product Endorsement from the State of AlaskaTauriga Sciences, Inc. received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska. Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program). Endorsement Applies to: Tauri-Gum™ Product Line. This Product Endorsement was issued on December 20, 2021 (AIH Registration Number: E_10119).공시 • Dec 19Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review BoardTauriga Sciences, Inc. announced that it has formally submitted its Clinical Study Protocol to the Institutional Review Board. The Company’s Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy. The purpose of this Clinical Study is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. Hyperemesis Gravidarum is also known as: Morning Sickness. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol.공시 • Sep 19Tauriga Sciences Inc. Products Offerings Now Available on Amazon PrimeTauriga Sciences, Inc. announced that its proprietary product offerings are now available on Amazon Prime. Currently, 3 SKUs of the Company’s brand Tauri-Gum™, as well as its Tauri-Pet™ dog treats – are available to Amazon Prime customers. Amazon Prime is a paid subscription program from Amazon which is available in various countries and gives users access to additional services otherwise unavailable or available at a premium to other Amazon customers. Services include same, one or two-day delivery of goods and streaming music, video, e-books, gaming and grocery shopping services. In April 2021, Amazon reported that Prime had more than 200 million subscribers worldwide. In other news, the Company continues to experience strong levels of revenue growth and new customer acquisition.공시 • Sep 14Tauriga Sciences Inc. Completes Funding of the Study Protocol Phase of Its Recently Initiated Clinical TrialTauriga Sciences, Inc. announced that it has completed the funding of the Study Protocol phase of its recently initiated Clinical Trial. This purpose of which, is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. The finalized Study Protocol (“Protocol”) will be submitted to, reviewed by, and subject to approval from a central Institutional Review Board (“IRB”). The Company’s expects to formally submit its Protocol to the IRB within the next 30 days. Recall that on August 31, 2021, the Company announced that it had initiated a clinical trial to examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum. The Company’s proposed Cannabidiol delivery system (via: sublingual absorption /oral mucosa), utilizes its proprietary Cannabidiol infused chewing gum platform. This focuses on Sublingual Delivery, which refers to the pharmacological route of administration by which substances diffuse into the blood through tissues under the tongue. The Company expects to develop “mission critical” versions of its proprietary chewing gum, incorporating varying concentrations of CBD (potentially combined with other substances). The Company will provide an update to shareholders once the IRB renders a decision with respect to this Protocol. The Company anticipates that this will occur within the next 90 days.공시 • Aug 05Tauriga Sciences Inc. Announces the Arrival of Product Inventory for its Enhanced Tauri-Gum Product LineTauriga Sciences, Inc. announced the arrival of product inventory for its enhanced Tauri-Gum™ product line (11 SKUs in Total). This inventory is available, immediately, on the Company’s E-Commerce website (www.taurigum.com). Additionally, the Company is focused on the commercial launch (of its Enhanced Tauri-Gum™ Product Line) to the retail marketplace. ENAHNCED Tauri-Gum™ CHEWING GUM PRODUCT LINE: SKU # 1): 25mg CBD Mint Flavor, SKU # 2): 25mg CBD Blood Orange Flavor, SKU # 3): 25mg CBD Pomegranate Flavor, SKU # 4): 25mg CBG Black Currant Flavor, SKU # 5): 25mg CBG Peach-Lemon Flavor, SKU # 6): 10mg DELTA 8 THC Evergreen Mint Flavor, SKU # 7): 60mg Vitamin C + 10mg Zinc Pear Bellini Flavor, SKU # 8): 50mg Caffeine Cherry Lime Rickey Flavor and SKU # 9): 2,000 IU Vitamin D3 Golden Raspberry Flavor. PARTNERSHIP WITH THINK BIG, LLC (SKUs # 10 & 11) - SKU # 10): 15mg CBD + 10mg CBG + 5mg Vitamin C + 10mg Zinc Honey Lemon Flavor (Frank White/Tauri-Gum™) and SKU #11): 25mg CBD Mint Flavor (Frank White/Tauri-Gum™).공시 • Jul 14+ 1 more updateTauriga Sciences Inc. Introduces Two Innovative Topical Products: CBD Infused Sunscreen Spray and Acai Fragrance Moisturizing Lip BalmTauriga Sciences, Inc. introduced its two newest, innovative, topical products: CBD infused Sunscreen Spray & Acai Fragrance Moisturizing Lip Balm. These two products are being manufactured, under the following brand name: Tauri-Sun. The company is continuing to augment its Topical offerings, to complement its diverse and innovative CBD & CBG edibles products. The company has listed an additional product on Amazon. The company’s crisply apple flavor Tauri-Pet dog treat is now available, for sale, on Amazon. The company is in the process of listing many additional products on Amazon, which (in some instances) may require some modification(s) of the packaging and labeling.공시 • Jun 02Tauriga Sciences Inc. Introduces Innovative New Product OfferingTauriga Sciences, Inc. introduced the company’s Super Deluxe Rainbow Pack, which is comprised of 1 Blister Pack (each of the 9 Tauri-Gum SKUs). Each Pack will also include a 10thBlister Pack “Mystery Flavor” and a limited Edition (intricately designed) dedicated retail box tray. The Company will contribute $3 from each Pack sold, to various charitable causes. The Company expects to launch this Super Pack during mid-June 2021 and believes that it will drive future E-Commerce sales growth. The original Rainbow Pack, launched during September 2020, was highly successful and has continually been popular with E-Commerce customers.공시 • May 28Tauriga Sciences Inc. Prepares for Major Upcoming Product Launch and Introduces Expanded Tauri-Gummies™ Product LineTauriga Sciences, Inc. announced its preparations for its major upcoming product launch as well as the expansion of its Tauri-Gummies™ product line. The Company has worked with great diligence to be Innovative, with respect to the enhancement of its products and product lines. The Company is confident in its ability to gain market share and is continuing to increase its salesforce and its visibility to a broad array of potential new customers. The Company is making final preparations for the upcoming launch of its enhanced Tauri-Gum™ product line (its product line). Expected to occur during early June 2021, this product launch will include: 5 SKUs of 25mg CBD & CBG infused chewing gum, 1 SKU of 10mg Delta 8 THC infused chewing gum, 3 SKUs of Cannabinoid free chewing gum (Vitamin C + Zinc, Caffeine, Vitamin D3) and 2 SKUs pursuant to License Agreement (to be disclosed within the near term). The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies™ product line. This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.공시 • Mar 18Tauriga Sciences Inc. Commences Development of Delta-8-Thc Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has commenced development of a Delta-8-Tetrahydrocannabinol (“Delta-8-THC” or “Delta-8”) infused version of Tauri-Gum™. Delta-8-THC infused products are legal when the ingredient has been derived from the Industrial Hemp plant (“Cannabis Sativa”) and does not contain more than 0.3% (1/333rdby dry weight composition) THC. The Company is focused on expanding both its product offerings and revenue opportunities, in a manner that is ethical, innovative, and fully compliant with Federal laws & regulations.공시 • Mar 16Tauriga Sciences Inc. Announces Upcoming Launch of Tauri-Gum™ CBD & CBG Infusion ConcentrationsTauriga Sciences, Inc. announced that it has assembled a territorial, on-the-ground (“field”), sales force – initially focused on seven U.S. cities: Nashville (TN), Miami (FL), Atlanta (GA), New York City (NY), Minneapolis (MN), Los Angeles (CA), and Houston (TX). The assembling of this sales force coincides with the Company’s upcoming launch of its increased Tauri-Gum™ CBD & CBG infusion concentrations (25mg/per Serving). Due to its success in reducing the Tauri-Gum™ basic factors of production costs, the Company anticipates no material price increases (“MSRP”).공시 • Mar 09Tauriga Sciences, Inc. Announces Board AppointmentsEffective March 8, 2021, Tauriga Sciences, Inc. appointed each of Messrs. James Rosati and Chris Sferruzzo to serve as members of its board of directors (the “Board). In 2017, Jim retired as the Chief Executive Officer and President of Beacon Mutual Insurance Company, a prominent Rhode Island based insurance carrier, after having been elevated to chief executive in 2007 to lead their successful turnaround through the implementation of over 100 new policies, and significantly improving both its corporate governance and cultural dynamics. From 2017 to present, Jim has held board memberships and/or advisory roles for a number of for profit and non-profit entities, and has also been an investor in both privately held and publicly traded company, including in the pharmaceuticals and healthcare industries. Mr. Sferruzzo currently serves as the Executive Vice President, Finance of Bozzutos Inc. Prior to joining Bozzuto’s, Mr. Sferruzzo was a senior portfolio manager at Lazard Asset Management.공시 • Mar 04Tauriga Sciences Inc. Showcases the Blister Pack Design for its 8th Tauri-Gum SKU, Golden Raspberry Flavor / Vitamin D3 InfusedTauriga Sciences, Inc. showcased the Blister Pack design for its 8th Tauri-Gum™ SKU: Golden Raspberry Flavor /Infused with Vitamin D3 (“D3 or Cholecalciferol”). Each piece of chewing gum is in infused with 50 Micrograms (“ug”) or 2,000 International Units (“IU”) of Vitamin D3. The Company now has 3 distinct, Cannabinoid-Free SKUs of Tauri-Gum™ to complement its 5 SKUs of CBD & CBG infused products. These 3 complementary Cannabinoid-Free Tauri-Gum™ SKUs create significant potential opportunities for the Company. In other news, the Company can confirm that it has increased the CBD and CBG infusion concentrations to 25 Milligrams (“mg”) per piece of chewing gum. This takes effect immediately and is incorporated into the Company’s current large production run (as referenced in its press release, dated: February 10, 2021). For this large production run (currently being completed), the Company has allocated $267,750. Lastly, the Company continues to experience overall strength and growth in its margin E-Commerce business segment. As of this morning, March 1, 2021, the Company received its 5,515th E-Commerce order. The Tauri-Gum™ Product Line now consists of 8 distinct SKUs: [3] Cannabidiol (“CBD”) Infused SKUs: (i) Color: Red - Pomegranate Flavor (10-25mg) (ii) Color: Orange - Blood Orange Flavor (10-25mg) (iii) Color: Blue - Mint Flavor (10-25mg). [2] Cannabigerol (“CBG”) Infused SKUs: (iv) Color: Yellow - Peach-Lemon Flavor (10-25mg) (v) Color: Purple - Black Currant Flavor (15-25mg). [3] Cannabinoid-Free (Vitamin C + Zinc, Caffeine, Vitamin D3) Infused SKUs: (vi) Color: Green - Pear Bellini Flavor (60mg Vitamin C + 10mg Zinc) (vii) Color: Pink - Cherry Lime Rickey Flavor (50mg Caffeine) (viii) Color: Coral/Gold - Golden Raspberry Flavor (50ug or 2,000 IU).공시 • Feb 26+ 1 more updateTauriga Sciences Inc. Confirms Commercial Launch of Tauri-Gum Product LineTauriga Sciences, Inc. confirmed the commercial launch of its flagship Tauri-Gum™ product line on Connecticut based online grocer and wholesaler Stock Up Express’ website.공시 • Feb 20Tauriga Sciences Inc. Launches Two New Product Offerings on its E-Commerce PlatformTauriga Sciences, Inc. announced the official launch of two new product offerings on its E-Commerce platform. These two new product offerings are the following: CBD Infused Linden Honey (Unit: Jar) & Rainbow Bath Bomb Special (Unit: 6 Pack). The following MSRPs have been established: CBD Infused Honey: $49.99 per Jar & Rainbow Bath Bomb Special: $69.99 each. The CBD Infused Linden Honey product offering is infused with 500mg of CBD per each Jar. Each Jar contains 20 servings, which translates into 25mg of CBD per serving. Additionally, this product is Kosher Certified and of the higher quality. Category: CBD Infused Edibles. The Rainbow Bath Bomb Special consists of 6 individual Tauri-Gum™ themed fragrance bath bombs. Three are infused with 100mg CBD (Pomegranate, Blood Orange, and Mint – Fragrances), Two are infused with 100mg CBG (Peach-Lemon and Black Currant – Fragrances), and One is infused with 60mg Vitamin C + 10mg Zinc (Pear Bellini Fragrance). Category: CBD Infused Topicals/Cosmetics.공시 • Feb 18Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/16/2021, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 13Tauriga Sciences Inc. to Commence Development of Its Full Spectrum CBD Infused Edibles Product LineTauriga Sciences, Inc. announced that it has commenced development of its first full spectrum Cannabidiol infused edibles product line. The Company plans to develop this above referenced product line, with the following attributes: Kosher Certified, Halal Certified, Vegan Formulation, Dairy-Free, Infused with Full Spectrum Hemp Extract All-Natural Flavors, Sugar Free/Diabetic Friendly Version(s), and Full Adherence to U.S. Federal Laws & Regulations. The Company expects to provide concrete details about this proposed full spectrum product line within the near term.공시 • Feb 10Tauriga Sciences, Inc. Establishes Two Additional UPC Category Classifications for its Brand Tauri-GumTauriga Sciences, Inc. announced that it has established two additional Universal Product Code (“UPC”) category classifications for its brand Tauri-Gum™. These additional classifications are: Tauri-Gum™ Cases (8 Retail Boxes) and Tauri-Gum™ Shipment Crates (48 Retail Boxes). Previously the Company had only secured UPCs, for the Individual Tauri-Gum™ Blister Pack and the Individual Tauri-Gum™ Retail Box. These additional UPC category classifications were secured in preparation for sizable wholesale orders and in anticipation of future demand from large retailers. UPC Barcodes Categories for Tauri-Gum™ Product Line: Blister Pack (8 pieces of chewing gum); Retail Box (10 blister packs); Case (8 Retail Boxes); Shipment Crate (48 Retail Boxes).공시 • Feb 03Tauriga Sciences Inc. Completes Development of 100% Vegetable Sourced Vitamin D3 (Cholecalciferol) Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has completed development of its proposed Vitamin D3 (“Cholecalciferol”) infused version of Tauri-Gum™, with each piece of chewing gum containing 50 Micrograms (“ug”) of Vitamin D3. After extensive Research & Development (“R & D”) efforts, the Company can confirm that the Vitamin D3 component is 100% derived from plant-based sources. The following flavor has been selected for this 8th Version (“SKU”) of Tauri-Gum™: Golden Raspberry. Vitamin D3, also known as Cholecalciferol, is type of Vitamin D which is made by the skin when it is exposed to sunlight; it is also found in some foods and can be consumed as a Dietary Supplement. The Company has successfully produced Samples of this proposed 8th Version of its Tauri-Gum™ Product Line. Vitamin D3, also known as Cholecalciferol, is type of Vitamin D which is made by the skin when it is exposed to sunlight; it is also found in some foods and can be consumed as a Dietary Supplement. The Company has successfully produced Samples of this proposed 8th Version of its Tauri-Gum™ Product Line. Values: 1 Microgram (“ug”) = 1/1,000,000thof a Gram (“gm”), 50 Micrograms (“ug”) = 2,000 International Units (“IU”).공시 • Jan 26Tauriga Sciences, Inc. Signs Major Distribution Agreement with Stock Up ExpressTauriga Sciences, Inc. announced that it has entered into a distribution agreement with Stock Up Express, a division of a leading total services distributor that generates more than $3 Billion in annual sales. Stock Up Express is based in Connecticut and is a leading web-based grocer and wholesaler with over 1,000,000 online visitors annually. The Agreement will be effective February 1, 2021, and shall remain in effect for a period of two (2) years thereafter, with automatic renewal for additional successive one (1) year terms. Under terms of the Agreement, Stock Up Express will market and resell the company’s flagship brand, Tauri-Gum™, to its large and diverse customer base of wholesalers and retail customers. The revenue sharing ratio established between Tauriga and Stock Up Express has the potential to create significant opportunity for both parties to this Agreement (solid gross margins). Tauri-Gum™ represents the first CBD edibles product/product line to be selected as part of the Stock Up Express network. The two Companies will jointly market Tauri-Gum™ to Stock Up Express’ customer base, with input by Tauriga on the content of such marketing information to attain consistency on message and to maximize sales. The Agreement allows for modification of product offerings, and Tauriga expects to offer additional items over the course of calendar year 2021.공시 • Jan 22Tauriga Sciences, Inc Receives E-Commerce OrderTauriga Sciences, Inc. confirmed that it has received its 5,000th E-Commerce order (on January 19th, 2021). The average order size ($ dollar amount), per individual online E-Commerce transaction, has been steadily increasing over the past months. The Company is confident that its highest margin E-Commerce business segment will continue to experience meaningful levels of growth.공시 • Jan 13Tauriga Sciences Inc. Renews Its Status as an Affiliate Vendor to the National Association of College StoresTauriga Sciences, Inc. announced that its status as an Affiliate Vendor (“Vendor”) has been renewed by the National Association of College Stores (“NACS”). As a Vendor to the NACS, the Company is part of the most comprehensive group of campus retailers working to provide the best services and selections to College students across the United States. Over the past year, the Company has received multiple Purchase Orders from College Campus Stores and has continued to experience strong levels of interest from industry buyers. The National Association of College Stores is the professional trade association of the $10 Billion campus store industry. The NACS represent nearly 4,000 campuses in the U.S. and Canada, and approximately 1,000 companies that supply goods and services to campus stores. Through educational events, productive Tradeshows, and award-winning publications, the NACS is the gateway to securing new customers and growing your business in the $10 Billion campus market. The annual NACS Tradeshow attracts more than 22,000 industry stakeholders from around the world. Buyers and sellers come together to conduct business, learn from one another and network. The expo is segmented into six categories: Fuel Equipment & Services, Food Equipment & Foodservice Programs, Candy/Snacks, Facility Development & Store Operations, Merchandise and Technology. The Company intends to operate a Virtual Exhibitor Booth at the upcoming NACS Campus Market Expo Tradeshow (“NACS Tradeshow”) – February 22nd-26th, 2021. Recall that last year, February 10th-11th, 2020, the Company operated a main floor Exhibitor Booth (# 518) at the 2020 NACS Tradeshow – which took place at the Ernest N. Morial Convention Center in New Orleans, Louisiana.공시 • Jan 06Tauriga Sciences Inc. Completes the Translations of its Tauri-Gum Packaging into 4 Additional Languages: French, Arabic, Hebrew, and JapaneseTauriga Sciences, Inc. announced that it has completed the translated versions of its Tauri-Gum™ packaging into the following 4 additional languages: French, Arabic, Hebrew, and Japanese. The Company contracted GTS Translation Services (“GTS”) to provide this service, important to the Company’s long-term growth strategy. In particular, the Company is actively pursuing potential opportunities to launch its Tauri-Gum™ product line in the Middle East. The Company’s Tauri-Gum™ product line is both Kosher Certified (Authority: Star-K) and Halal Certified (Authority: Etimad). The Company’s international presence, via its E-Commerce customer base, continues to expand in terms of its customer base. Recently, the Company has received E-Commerce orders from: Israel, Kuwait, United Kingdom, and Australia. Previously, on December 21, 2020, the Company announced that it had successfully translated its Tauri-Gum™ packaging into Mandarin Chinese (“Mandarin”). At this time, the Company’s Tauri-Gum™ packaging is available in the following 6 languages: English, Mandarin Chinese, French, Arabic, Hebrew, and Japanese.공시 • Dec 30Tauriga Sciences Inc. Expands Its CBD Infused Skin Care Offerings to Include More Than 10 Different ProductsTauriga Sciences, Inc. announced that its recently launched Skin Care Offerings have now been expanded to include more than 10 distinct CBD Infused products. These product offerings include CBD Infused: Face Moisturizer (100mg), Anti-Wrinkle Cream (30mg), Collagen/Tightening/Detoxifying Face Masks (4.20mg), Lip Balm (5mg), Hand & Foot Cream (N/A), Transdermal Patch (35mg), Massage & Body Oil (120mg), Body Spray (120mg), and Roll-On Product (240mg).공시 • Dec 25Tauriga Sciences Inc. to Expand its Existing Product Line of CBD Infused Bath Bombs, Branded Under the Tauri-Gum NameTauriga Sciences, Inc. announced the planned expansion of its launched product line of Cannabidiol infused Bath Bombs – branded under Tauri-Gum. This planned expansion will include 2 distinct Cannabigerol infused Bath Bomb fragrances (Peach-Lemon & Black Currant) each will contain 100mg of CBG. There will also be a Pear Bellini Bath Bomb fragrance the formulation of which is still under development. On December 3, 2020, the Company disclosed the launch of 3 distinct CBD infused Bath Bomb fragrances: Blood Orange, Mint, and Pomegranate; each infused with 100mg of CBD and sold for $13.99 per Unit.공시 • Dec 20Tauriga Sciences Inc. Enters into Master Services Agreement with Clinical Strategies & Tactics, Inc. to Resume the Clinical Development of Its Anti-Nausea Pharmaceutical Grade Version of Tauri-GumTauriga Sciences, Inc. announced that it has entered into a Master Services Agreement with North Carolina based Clinical Strategies & Tactics, Inc. to resume the clinical development of its proposed “Anti-Nausea” pharmaceutical grade version of Tauri-Gum™. CSTI will largely be focusing its efforts on the following: Pharmaceutical Development Strategy (“I.”), Commercialization Strategy (“II.”), and Funding Strategy (“III.”). The Company will be working closely with CSTI’s Founder & CEO, JoAnn C. Giannone (“Ms. Giannone”), who has over 25 years’ experience effectively leading companies through the drug and medical device development process (Prior to founding CSTI, Ms. Giannone held leadership positions with Johnson & Johnson and Pharmacia). The Company intends to fund the entirety of this Agreement, before the end of Calendar 2020.공시 • Dec 18Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed “Anti-Nausea” Pharmaceutical Grade Version of Tauri-GumTauriga Sciences, Inc. announced the resumption of clinical development efforts, concerning its proposed “Anti-Nausea” pharmaceutical grade version of Tauri-Gum™. The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work). The delivery system for this proposed Pharmaceutical version is a modified version (substantially higher concentration of CBD) of the existing “Tauri-Gum™” chewing gum formulation based on continued research and development.공시 • Dec 13Tauriga Sciences Inc. Commences Development of Vegan, CBD Infused Pet TreatTauriga Sciences, Inc. announced that it has commenced the development of a Vegan, Cannabidiol (“CBD”) infused Pet Food Treat (“Pet Treat”). The Company has contracted an industry expert to help with: formulations, specifications, designs, regulations, and certifications. The Company’s aim is to commercially launch its proposed Pet Treat product, during March 2021. Recall that on June 8, 2020, the Company issued the press release: “Tauriga Sciences Inc. Taking Concrete Steps to Expand into the Fast-Growing CBD Infused Pet Food Market Segment.” For the Year 2020, the U.S. pet treat market is projected at $7 Billion – driven by CBD & Other Ingredient trends.공시 • Dec 10Tauriga Sciences, Inc. Announces New Product Offering to Help Ensure the Expansion and Diversification of its Proprietary Product OfferingsTauriga Sciences, Inc. ('Tauriga'or the 'Company') announced a new product offering to help ensure the expansion and diversification of the Company’s proprietary product offerings. This is in response to the Company’s fast growing E-Commerce business segment as well as the continually increasing customer base. After evaluating numerous potential new product offerings, the Company has decided to launch this CBD Infused Linden Honey (“CBD Honey”) product. This new product will be infused with 500mg of CBD per Jar (“Unit”) and each jar contains 20 servings (25mg CBD per serving). This product will also be Kosher Certified and of the highest quality. The Manufacturer’s Suggested Retail Price (“MSRP”) is expected to be set at USD 49.99 per Jar. This CBD Honey (16 oz. Jars) will be available exclusively on the Company’s E-Commerce Website. Raw Linden Honey is a tough honey to produce as the Linden trees are only in bloom 7-10 days annually. The honey has been described as having a very fresh aroma, described as: minty, menthol, camphor, balsamic, etc. Excellent honey for tea, desserts, muffins, hot cereal - you name it! The blooming season for Linden trees is generally the first week in July in the Northern Hemisphere.공시 • Dec 04Tauriga Sciences, Inc. Introduces its Product Line of CBD Infused Bath Bombs Under the Tauri-Gum BrandTauriga Sciences, Inc. introduced its newest product line: CBD Infused Bath Bombs (Spherical Shape), under the Tauri-Gum™ brand. Over the past few weeks, the Company performed a Pilot Test – offering Blood Orange fragrance Bath Bombs – on its Shopify E-Commerce Platform (www.taurigum.com). All of the “Pilot Test” inventory was sold out and the customers reported positive reviews. This Bath Bomb product line is being launched with 3 distinct fragrances: Blood Orange, Mint, and Pomegranate. Each Bath Bomb is infused with 100mg of CBD isolate and will be sold for $13.99 per unit. This Bath Bomb product line is categorized as: CBD Infused Cosmetics.공시 • Dec 03Tauriga Sciences Inc. to Commence Development of Caffeine Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has commenced development of a caffeine infused version of Tauri-Gum™. This new proposed product offering will contain 100mg of Caffeine in each piece of chewing gum; roughly equivalent to a standard 8oz cup of coffee. At this point, the Company believes that this product will incorporate the following all-natural Flavor(s); Cherry Cola. The anticipated Manufacturer’s Suggested Retail Price (MSRP): $8.99 per Blister Pack. The Company has decided to develop this 2nd Tauri-Gum™ SKU that does NOT contain any Phyto-Cannabinoids (Pear Bellini Flavor Tauri-Gum™ being the 1st SKU). This decision was partially in response to ongoing conversations with major retailers and other prospective future customers. Anticipated Launch Date: During January-February 2021 (4th Fiscal Quarter of 2021).공시 • Nov 26Tauriga Sciences, Inc. Officially Transitions Its E-Commerce Payment Processing to Square Inc. & Is Now Approved to Accept American Express Credit CardsTauriga Sciences, Inc. announced the official transition of its E-Commerce payment processing to Square Inc. From now on, the Company’s E-Commerce platform no longer has type of individual transaction ($) limit imposed (previously it had been set at $3,000). The Company is also pleased to disclose that its E-Commerce website (www.taurigum.com) is now approved to accept American Express credit cards for online payments (previously this was limited to: Visa and Mastercard).공시 • Nov 19Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New Covid-19 TestsAs previously announced, during April 2020, Tauriga Sciences, Inc. and Aegea Biotechnologies, Inc. have entered into a collaboration agreement to develop COVID-19 (novel coronavirus) assays. Aegea has made substantial progress in designing and developing two different, next generation assays for SARS-CoV-2. Aegea’s first new SARS-CoV-2 test under development is designed to have several advantages compared with other COVID-19 PCR assays as a result of the single nucleotide discrimination capacities of its patented Switch-Blocker technology. The assay is designed to detect low copy numbers of viral RNA, therefore potentially detecting the viral load at much lower levels than conventional PCR-based assays. If successful, this would be an important differentiating feature as it has been reported that asymptomatic patients are able to infect others. As designed, the COVID-19 PCR assay would also allow for superior specificity in its ability to identify the different strains of SARS-CoV-2, as well as distinguish SARS-CoV-2, which is associated with COVID-19, from other common forms of the SARS virus. Aegea’s second SARS-CoV-2 test under development also makes use of its patented technologies. This test will be performed on very simple, proprietary, affordable devices using saliva samples. Aegea’s second SARS-CoV-2 test is designed to be appropriate for testing at point-of-care and remote settings.공시 • Nov 17Tauriga Sciences, Inc. Receives Its 4,000th E-Commerce OrderTauriga Sciences, Inc. announced that it has received its 4,000th online E-Commerce Order through its dedicated E-commerce website (www.taurigum.com). The Company continues to realize positive trends with respect to its highest margin E-Commerce business segment, such as: growing numbers of repeat customers, increase in average $amount per transaction, numerous testimonials, 5-Star product ratings, and continued robust sales of its Rainbow Pack.공시 • Nov 07Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for Its Cannabis (Cbd & Cbg) Infused Chewing Gum Product LineTauriga Sciences, Inc. announced that it is experiencing greater overall market acceptance for its Cannabis (“CBD” & “CBG”) infused chewing gum product line: Tauri-Gum™. This improved legal and regulatory landscape, as it pertains to CBD Edibles, has created important new opportunities for the Company. In recent days this has translated into strong levels of revenue growth as well as market acceptance. The Company is working with great determination to capitalize on this preferable business environment.공시 • Oct 27Tauriga Sciences, Inc. to Commence 3rd Production Run of its CBD Infused Gum Drop Product – Branded As: Tauri-GummiesTauriga Sciences, Inc. announced plans to commence a 3rd production run of its Cannabidiol (“CBD”) infused Gum Drop product, branded as: Tauri-Gummies™. The company is incorporating a slight re-formulation for this 3rd production run, to improve this highly popular CBD edibles product. The company anticipates that this 3rd production run will be comprised of 3,000 – 5,000 Jars of Tauri-Gummies™. Each Jar contains 24 gum drops, with each gum drop infused with 25mg of CBD isolate (600mg CBD per Jar). The gum drops are manufactured in 4 distinct flavors: Cherry (Red), Orange (Orange), Lemon (Yellow), Lime (Green).공시 • Oct 08Tauriga Sciences, Inc. Enters into Strategic Alliance with Think Big, LlcTauriga Sciences, Inc. announced that it has entered into a Strategic Alliance with Think Big, LLC. This new partnership includes a global licensing deal to bring co-branded CBD & CBG products to market.공시 • Oct 07Tauriga Sciences, Inc. announced that it has received $0.135 million in fundingTauriga Sciences, Inc. (OTCPK:TAUG) announced that it has completed a private placement of a non-convertible promissory note for gross proceeds of $135,000 on October 6, 2020. The transaction included participation from an institutional investor. The note bears a fixed interest of 10% per annum, with a built in 6-month grace period. The note will be repaid in 7 equal monthly payments of $21,214.29 from April 5, 2021 through October 5, 2021.공시 • Sep 30Tauriga Sciences Inc. Continues to Increase its National Network of DSD Distributors to Support Ongoing National Launch of its Brand Tauri-GumTauriga Sciences, Inc. announced the assembling of a national network of Direct Store Delivery Distributors in support of the ongoing national launch of its brand Tauri-Gum. Through its previously disclosed Agreement with Mr. Checkout Distributors, the company is continually increasing its network of DSD Distributors – which have the capability to place Tauri-Gum in many thousands of retail locations across the country. The company plans to issue future updates, as this national network continues to grow and strengthen. In other news, the company has entered into a major Joint Venture Partnership with a Los Angeles based firm. Full details of this important alliance and its positive attributes will be disclosed over the coming days.공시 • Sep 29Tauriga Sciences, Inc. Becomes Vendor to Major Convenience Store & Gas Station Chain: Wawa, IncTauriga Sciences, Inc. announced that it has become a vendor to Wawa, Inc. The company has already presented its Tauri-Gum™ product line to the Wawa Purchasing Network. On Friday, September 25, 2020, the Company signed its Vendor Agreement with Wawa, Inc.공시 • Sep 26Tauriga Sciences, Inc. Confirms Arrival of its Pear Bellini Flavor Tauri-Gum InventoryTauriga Sciences, Inc. announced the arrival of its Pear Bellini flavor Vitamin C & Zinc (“Immune Booster”) infused Tauri-Gum™ inventory – at its E-Commerce fulfillment center. This product is the Company’s only version of Tauri-Gum™ that contains NO Phyto-cannabinoids (i.e. CBD or CBG). Pear Bellini Tauri-Gum™ is now available on the Company’s E-Commerce website (www.taurigum.com). Each Blister Pack of Pear Bellini Tauri-Gum™ contains 480mg Vitamin C and 80mg Zinc -- Manufacturer’s Suggested Retail Price (“MSRP”): $12.99 per Blister Pack. The Company’s Pear Bellini Tauri-Gum™ is: Kosher Certified, Halal Certified, Vegan Formulated, NON-GMO, Allergen Free, Gluten Free, Contains NO Phytocannabinoids, Lab Tested, All-Natural Flavors, and 100% Made in the USA. In other news, the Company officially launched its highly anticipated Rainbow Deluxe Sampler Pack on September 20, 2020. The Company has been experiencing very strong levels of demand for its Rainbow Pack and is now shipping out many dozens of completed orders from its E-Commerce fulfillment facility.공시 • Sep 18Tauriga Sciences, Inc. to Launch Rainbow Deluxe Sampler PackTauriga Sciences, Inc. announced that Rainbow Deluxe Sampler Pack will officially launch on September 20 on the Company’s E-Commerce platform. Pre-Orders for the Rainbow Pack have been robust, and the Company expects to announce a major partnership to enhance both the profile and scale of this launch.공시 • Sep 17Tauriga Sciences, Inc. Showcases Final Design of Point of Sale Display Case for Select Retail LocationsTauriga Sciences, Inc. showcased the illustrative design of the Final version of its Point of Sale (“POS”) display case for select retail locations. This display case will be allocated to select, high volume, retail locations in support of upcoming National Roll-Out (“National Launch”) of Tauri-Gum™ brand (expected to commence during September 2020).공시 • Jul 17Tauriga Sciences, Inc. announced that it has received $0.035 million in fundingTauriga Sciences, Inc. (OTCPK:TAUG) announced a private placement of 700,000 common shares at a price of $0.05 per share for gross proceeds of $35,000 on July 10, 2020. The transaction included participation from Chief Executive Officer of the company, Seth M. Shaw. The shares issued are restricted in nature.주주 수익률TAUGUS PharmaceuticalsUS 시장7D0%2.6%2.5%1Y0%41.5%26.4%전체 주주 수익률 보기수익률 대 산업: TAUG은 지난 1년 동안 41.5%의 수익을 기록한 US Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: TAUG은 지난 1년 동안 26.4%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is TAUG's price volatile compared to industry and market?TAUG volatilityTAUG Average Weekly Movementn/aPharmaceuticals Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.5%10% least volatile stocks in US Market3.1%안정적인 주가: TAUG는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: Insufficient data to determine TAUG의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2001n/aSeth Shawwww.tauriga.com더 보기Tauriga Sciences, Inc. 기초 지표 요약Tauriga Sciences의 순이익과 매출은 시가총액과 어떻게 비교됩니까?TAUG 기초 통계시가총액US$348.00순이익 (TTM)-US$6.13m매출 (TTM)US$313.50k0.0x주가매출비율(P/S)0.0x주가수익비율(P/E)TAUG는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표TAUG 손익계산서 (TTM)매출US$313.50k매출원가US$154.24k총이익US$159.26k기타 비용US$6.29m순이익-US$6.13m최근 보고된 실적Dec 31, 2021다음 실적 발표일해당 없음주당순이익(EPS)0총이익률0.00%순이익률0.00%부채/자본 비율0.0%TAUG의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/05/08 21:51종가2024/05/08 00:00수익2021/12/31연간 수익2021/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Tauriga Sciences, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Aug 17Tauriga Sciences, Inc. announced delayed 10-Q filingOn 08/16/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 15Tauriga Sciences, Inc. announced delayed amended 10-K filingOn 07/14/2022, Tauriga Sciences, Inc. announced that they will be unable to file their amended 10-K by the deadline required by the SEC.
공시 • Jul 01Tauriga Sciences, Inc. announced delayed annual 10-K filingOn 06/30/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 16Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/15/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Dec 22Tauriga Sciences Inc. Receives Product Endorsement from the State of AlaskaTauriga Sciences, Inc. received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska. Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program). Endorsement Applies to: Tauri-Gum™ Product Line. This Product Endorsement was issued on December 20, 2021 (AIH Registration Number: E_10119).
공시 • Dec 19Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review BoardTauriga Sciences, Inc. announced that it has formally submitted its Clinical Study Protocol to the Institutional Review Board. The Company’s Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy. The purpose of this Clinical Study is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. Hyperemesis Gravidarum is also known as: Morning Sickness. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol.
공시 • Aug 17Tauriga Sciences, Inc. announced delayed 10-Q filingOn 08/16/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 15Tauriga Sciences, Inc. announced delayed amended 10-K filingOn 07/14/2022, Tauriga Sciences, Inc. announced that they will be unable to file their amended 10-K by the deadline required by the SEC.
공시 • Jul 01Tauriga Sciences, Inc. announced delayed annual 10-K filingOn 06/30/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 16Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/15/2022, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Dec 22Tauriga Sciences Inc. Receives Product Endorsement from the State of AlaskaTauriga Sciences, Inc. received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska. Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program). Endorsement Applies to: Tauri-Gum™ Product Line. This Product Endorsement was issued on December 20, 2021 (AIH Registration Number: E_10119).
공시 • Dec 19Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review BoardTauriga Sciences, Inc. announced that it has formally submitted its Clinical Study Protocol to the Institutional Review Board. The Company’s Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy. The purpose of this Clinical Study is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. Hyperemesis Gravidarum is also known as: Morning Sickness. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol.
공시 • Sep 19Tauriga Sciences Inc. Products Offerings Now Available on Amazon PrimeTauriga Sciences, Inc. announced that its proprietary product offerings are now available on Amazon Prime. Currently, 3 SKUs of the Company’s brand Tauri-Gum™, as well as its Tauri-Pet™ dog treats – are available to Amazon Prime customers. Amazon Prime is a paid subscription program from Amazon which is available in various countries and gives users access to additional services otherwise unavailable or available at a premium to other Amazon customers. Services include same, one or two-day delivery of goods and streaming music, video, e-books, gaming and grocery shopping services. In April 2021, Amazon reported that Prime had more than 200 million subscribers worldwide. In other news, the Company continues to experience strong levels of revenue growth and new customer acquisition.
공시 • Sep 14Tauriga Sciences Inc. Completes Funding of the Study Protocol Phase of Its Recently Initiated Clinical TrialTauriga Sciences, Inc. announced that it has completed the funding of the Study Protocol phase of its recently initiated Clinical Trial. This purpose of which, is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. The finalized Study Protocol (“Protocol”) will be submitted to, reviewed by, and subject to approval from a central Institutional Review Board (“IRB”). The Company’s expects to formally submit its Protocol to the IRB within the next 30 days. Recall that on August 31, 2021, the Company announced that it had initiated a clinical trial to examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum. The Company’s proposed Cannabidiol delivery system (via: sublingual absorption /oral mucosa), utilizes its proprietary Cannabidiol infused chewing gum platform. This focuses on Sublingual Delivery, which refers to the pharmacological route of administration by which substances diffuse into the blood through tissues under the tongue. The Company expects to develop “mission critical” versions of its proprietary chewing gum, incorporating varying concentrations of CBD (potentially combined with other substances). The Company will provide an update to shareholders once the IRB renders a decision with respect to this Protocol. The Company anticipates that this will occur within the next 90 days.
공시 • Aug 05Tauriga Sciences Inc. Announces the Arrival of Product Inventory for its Enhanced Tauri-Gum Product LineTauriga Sciences, Inc. announced the arrival of product inventory for its enhanced Tauri-Gum™ product line (11 SKUs in Total). This inventory is available, immediately, on the Company’s E-Commerce website (www.taurigum.com). Additionally, the Company is focused on the commercial launch (of its Enhanced Tauri-Gum™ Product Line) to the retail marketplace. ENAHNCED Tauri-Gum™ CHEWING GUM PRODUCT LINE: SKU # 1): 25mg CBD Mint Flavor, SKU # 2): 25mg CBD Blood Orange Flavor, SKU # 3): 25mg CBD Pomegranate Flavor, SKU # 4): 25mg CBG Black Currant Flavor, SKU # 5): 25mg CBG Peach-Lemon Flavor, SKU # 6): 10mg DELTA 8 THC Evergreen Mint Flavor, SKU # 7): 60mg Vitamin C + 10mg Zinc Pear Bellini Flavor, SKU # 8): 50mg Caffeine Cherry Lime Rickey Flavor and SKU # 9): 2,000 IU Vitamin D3 Golden Raspberry Flavor. PARTNERSHIP WITH THINK BIG, LLC (SKUs # 10 & 11) - SKU # 10): 15mg CBD + 10mg CBG + 5mg Vitamin C + 10mg Zinc Honey Lemon Flavor (Frank White/Tauri-Gum™) and SKU #11): 25mg CBD Mint Flavor (Frank White/Tauri-Gum™).
공시 • Jul 14+ 1 more updateTauriga Sciences Inc. Introduces Two Innovative Topical Products: CBD Infused Sunscreen Spray and Acai Fragrance Moisturizing Lip BalmTauriga Sciences, Inc. introduced its two newest, innovative, topical products: CBD infused Sunscreen Spray & Acai Fragrance Moisturizing Lip Balm. These two products are being manufactured, under the following brand name: Tauri-Sun. The company is continuing to augment its Topical offerings, to complement its diverse and innovative CBD & CBG edibles products. The company has listed an additional product on Amazon. The company’s crisply apple flavor Tauri-Pet dog treat is now available, for sale, on Amazon. The company is in the process of listing many additional products on Amazon, which (in some instances) may require some modification(s) of the packaging and labeling.
공시 • Jun 02Tauriga Sciences Inc. Introduces Innovative New Product OfferingTauriga Sciences, Inc. introduced the company’s Super Deluxe Rainbow Pack, which is comprised of 1 Blister Pack (each of the 9 Tauri-Gum SKUs). Each Pack will also include a 10thBlister Pack “Mystery Flavor” and a limited Edition (intricately designed) dedicated retail box tray. The Company will contribute $3 from each Pack sold, to various charitable causes. The Company expects to launch this Super Pack during mid-June 2021 and believes that it will drive future E-Commerce sales growth. The original Rainbow Pack, launched during September 2020, was highly successful and has continually been popular with E-Commerce customers.
공시 • May 28Tauriga Sciences Inc. Prepares for Major Upcoming Product Launch and Introduces Expanded Tauri-Gummies™ Product LineTauriga Sciences, Inc. announced its preparations for its major upcoming product launch as well as the expansion of its Tauri-Gummies™ product line. The Company has worked with great diligence to be Innovative, with respect to the enhancement of its products and product lines. The Company is confident in its ability to gain market share and is continuing to increase its salesforce and its visibility to a broad array of potential new customers. The Company is making final preparations for the upcoming launch of its enhanced Tauri-Gum™ product line (its product line). Expected to occur during early June 2021, this product launch will include: 5 SKUs of 25mg CBD & CBG infused chewing gum, 1 SKU of 10mg Delta 8 THC infused chewing gum, 3 SKUs of Cannabinoid free chewing gum (Vitamin C + Zinc, Caffeine, Vitamin D3) and 2 SKUs pursuant to License Agreement (to be disclosed within the near term). The Company is also planning a June 2021 launch of its expanded and enhanced Tauri-Gummies™ product line. This product launch will include: Original 25mg CBD infused gum drops (re-formulated without artificial colors), 25mg Delta 8 THC infused Blue Raspberry gummies, and 25mg Delta 8 THC + Melatonin + infused Wild Blueberry gummies.
공시 • Mar 18Tauriga Sciences Inc. Commences Development of Delta-8-Thc Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has commenced development of a Delta-8-Tetrahydrocannabinol (“Delta-8-THC” or “Delta-8”) infused version of Tauri-Gum™. Delta-8-THC infused products are legal when the ingredient has been derived from the Industrial Hemp plant (“Cannabis Sativa”) and does not contain more than 0.3% (1/333rdby dry weight composition) THC. The Company is focused on expanding both its product offerings and revenue opportunities, in a manner that is ethical, innovative, and fully compliant with Federal laws & regulations.
공시 • Mar 16Tauriga Sciences Inc. Announces Upcoming Launch of Tauri-Gum™ CBD & CBG Infusion ConcentrationsTauriga Sciences, Inc. announced that it has assembled a territorial, on-the-ground (“field”), sales force – initially focused on seven U.S. cities: Nashville (TN), Miami (FL), Atlanta (GA), New York City (NY), Minneapolis (MN), Los Angeles (CA), and Houston (TX). The assembling of this sales force coincides with the Company’s upcoming launch of its increased Tauri-Gum™ CBD & CBG infusion concentrations (25mg/per Serving). Due to its success in reducing the Tauri-Gum™ basic factors of production costs, the Company anticipates no material price increases (“MSRP”).
공시 • Mar 09Tauriga Sciences, Inc. Announces Board AppointmentsEffective March 8, 2021, Tauriga Sciences, Inc. appointed each of Messrs. James Rosati and Chris Sferruzzo to serve as members of its board of directors (the “Board). In 2017, Jim retired as the Chief Executive Officer and President of Beacon Mutual Insurance Company, a prominent Rhode Island based insurance carrier, after having been elevated to chief executive in 2007 to lead their successful turnaround through the implementation of over 100 new policies, and significantly improving both its corporate governance and cultural dynamics. From 2017 to present, Jim has held board memberships and/or advisory roles for a number of for profit and non-profit entities, and has also been an investor in both privately held and publicly traded company, including in the pharmaceuticals and healthcare industries. Mr. Sferruzzo currently serves as the Executive Vice President, Finance of Bozzutos Inc. Prior to joining Bozzuto’s, Mr. Sferruzzo was a senior portfolio manager at Lazard Asset Management.
공시 • Mar 04Tauriga Sciences Inc. Showcases the Blister Pack Design for its 8th Tauri-Gum SKU, Golden Raspberry Flavor / Vitamin D3 InfusedTauriga Sciences, Inc. showcased the Blister Pack design for its 8th Tauri-Gum™ SKU: Golden Raspberry Flavor /Infused with Vitamin D3 (“D3 or Cholecalciferol”). Each piece of chewing gum is in infused with 50 Micrograms (“ug”) or 2,000 International Units (“IU”) of Vitamin D3. The Company now has 3 distinct, Cannabinoid-Free SKUs of Tauri-Gum™ to complement its 5 SKUs of CBD & CBG infused products. These 3 complementary Cannabinoid-Free Tauri-Gum™ SKUs create significant potential opportunities for the Company. In other news, the Company can confirm that it has increased the CBD and CBG infusion concentrations to 25 Milligrams (“mg”) per piece of chewing gum. This takes effect immediately and is incorporated into the Company’s current large production run (as referenced in its press release, dated: February 10, 2021). For this large production run (currently being completed), the Company has allocated $267,750. Lastly, the Company continues to experience overall strength and growth in its margin E-Commerce business segment. As of this morning, March 1, 2021, the Company received its 5,515th E-Commerce order. The Tauri-Gum™ Product Line now consists of 8 distinct SKUs: [3] Cannabidiol (“CBD”) Infused SKUs: (i) Color: Red - Pomegranate Flavor (10-25mg) (ii) Color: Orange - Blood Orange Flavor (10-25mg) (iii) Color: Blue - Mint Flavor (10-25mg). [2] Cannabigerol (“CBG”) Infused SKUs: (iv) Color: Yellow - Peach-Lemon Flavor (10-25mg) (v) Color: Purple - Black Currant Flavor (15-25mg). [3] Cannabinoid-Free (Vitamin C + Zinc, Caffeine, Vitamin D3) Infused SKUs: (vi) Color: Green - Pear Bellini Flavor (60mg Vitamin C + 10mg Zinc) (vii) Color: Pink - Cherry Lime Rickey Flavor (50mg Caffeine) (viii) Color: Coral/Gold - Golden Raspberry Flavor (50ug or 2,000 IU).
공시 • Feb 26+ 1 more updateTauriga Sciences Inc. Confirms Commercial Launch of Tauri-Gum Product LineTauriga Sciences, Inc. confirmed the commercial launch of its flagship Tauri-Gum™ product line on Connecticut based online grocer and wholesaler Stock Up Express’ website.
공시 • Feb 20Tauriga Sciences Inc. Launches Two New Product Offerings on its E-Commerce PlatformTauriga Sciences, Inc. announced the official launch of two new product offerings on its E-Commerce platform. These two new product offerings are the following: CBD Infused Linden Honey (Unit: Jar) & Rainbow Bath Bomb Special (Unit: 6 Pack). The following MSRPs have been established: CBD Infused Honey: $49.99 per Jar & Rainbow Bath Bomb Special: $69.99 each. The CBD Infused Linden Honey product offering is infused with 500mg of CBD per each Jar. Each Jar contains 20 servings, which translates into 25mg of CBD per serving. Additionally, this product is Kosher Certified and of the higher quality. Category: CBD Infused Edibles. The Rainbow Bath Bomb Special consists of 6 individual Tauri-Gum™ themed fragrance bath bombs. Three are infused with 100mg CBD (Pomegranate, Blood Orange, and Mint – Fragrances), Two are infused with 100mg CBG (Peach-Lemon and Black Currant – Fragrances), and One is infused with 60mg Vitamin C + 10mg Zinc (Pear Bellini Fragrance). Category: CBD Infused Topicals/Cosmetics.
공시 • Feb 18Tauriga Sciences, Inc. announced delayed 10-Q filingOn 02/16/2021, Tauriga Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 13Tauriga Sciences Inc. to Commence Development of Its Full Spectrum CBD Infused Edibles Product LineTauriga Sciences, Inc. announced that it has commenced development of its first full spectrum Cannabidiol infused edibles product line. The Company plans to develop this above referenced product line, with the following attributes: Kosher Certified, Halal Certified, Vegan Formulation, Dairy-Free, Infused with Full Spectrum Hemp Extract All-Natural Flavors, Sugar Free/Diabetic Friendly Version(s), and Full Adherence to U.S. Federal Laws & Regulations. The Company expects to provide concrete details about this proposed full spectrum product line within the near term.
공시 • Feb 10Tauriga Sciences, Inc. Establishes Two Additional UPC Category Classifications for its Brand Tauri-GumTauriga Sciences, Inc. announced that it has established two additional Universal Product Code (“UPC”) category classifications for its brand Tauri-Gum™. These additional classifications are: Tauri-Gum™ Cases (8 Retail Boxes) and Tauri-Gum™ Shipment Crates (48 Retail Boxes). Previously the Company had only secured UPCs, for the Individual Tauri-Gum™ Blister Pack and the Individual Tauri-Gum™ Retail Box. These additional UPC category classifications were secured in preparation for sizable wholesale orders and in anticipation of future demand from large retailers. UPC Barcodes Categories for Tauri-Gum™ Product Line: Blister Pack (8 pieces of chewing gum); Retail Box (10 blister packs); Case (8 Retail Boxes); Shipment Crate (48 Retail Boxes).
공시 • Feb 03Tauriga Sciences Inc. Completes Development of 100% Vegetable Sourced Vitamin D3 (Cholecalciferol) Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has completed development of its proposed Vitamin D3 (“Cholecalciferol”) infused version of Tauri-Gum™, with each piece of chewing gum containing 50 Micrograms (“ug”) of Vitamin D3. After extensive Research & Development (“R & D”) efforts, the Company can confirm that the Vitamin D3 component is 100% derived from plant-based sources. The following flavor has been selected for this 8th Version (“SKU”) of Tauri-Gum™: Golden Raspberry. Vitamin D3, also known as Cholecalciferol, is type of Vitamin D which is made by the skin when it is exposed to sunlight; it is also found in some foods and can be consumed as a Dietary Supplement. The Company has successfully produced Samples of this proposed 8th Version of its Tauri-Gum™ Product Line. Vitamin D3, also known as Cholecalciferol, is type of Vitamin D which is made by the skin when it is exposed to sunlight; it is also found in some foods and can be consumed as a Dietary Supplement. The Company has successfully produced Samples of this proposed 8th Version of its Tauri-Gum™ Product Line. Values: 1 Microgram (“ug”) = 1/1,000,000thof a Gram (“gm”), 50 Micrograms (“ug”) = 2,000 International Units (“IU”).
공시 • Jan 26Tauriga Sciences, Inc. Signs Major Distribution Agreement with Stock Up ExpressTauriga Sciences, Inc. announced that it has entered into a distribution agreement with Stock Up Express, a division of a leading total services distributor that generates more than $3 Billion in annual sales. Stock Up Express is based in Connecticut and is a leading web-based grocer and wholesaler with over 1,000,000 online visitors annually. The Agreement will be effective February 1, 2021, and shall remain in effect for a period of two (2) years thereafter, with automatic renewal for additional successive one (1) year terms. Under terms of the Agreement, Stock Up Express will market and resell the company’s flagship brand, Tauri-Gum™, to its large and diverse customer base of wholesalers and retail customers. The revenue sharing ratio established between Tauriga and Stock Up Express has the potential to create significant opportunity for both parties to this Agreement (solid gross margins). Tauri-Gum™ represents the first CBD edibles product/product line to be selected as part of the Stock Up Express network. The two Companies will jointly market Tauri-Gum™ to Stock Up Express’ customer base, with input by Tauriga on the content of such marketing information to attain consistency on message and to maximize sales. The Agreement allows for modification of product offerings, and Tauriga expects to offer additional items over the course of calendar year 2021.
공시 • Jan 22Tauriga Sciences, Inc Receives E-Commerce OrderTauriga Sciences, Inc. confirmed that it has received its 5,000th E-Commerce order (on January 19th, 2021). The average order size ($ dollar amount), per individual online E-Commerce transaction, has been steadily increasing over the past months. The Company is confident that its highest margin E-Commerce business segment will continue to experience meaningful levels of growth.
공시 • Jan 13Tauriga Sciences Inc. Renews Its Status as an Affiliate Vendor to the National Association of College StoresTauriga Sciences, Inc. announced that its status as an Affiliate Vendor (“Vendor”) has been renewed by the National Association of College Stores (“NACS”). As a Vendor to the NACS, the Company is part of the most comprehensive group of campus retailers working to provide the best services and selections to College students across the United States. Over the past year, the Company has received multiple Purchase Orders from College Campus Stores and has continued to experience strong levels of interest from industry buyers. The National Association of College Stores is the professional trade association of the $10 Billion campus store industry. The NACS represent nearly 4,000 campuses in the U.S. and Canada, and approximately 1,000 companies that supply goods and services to campus stores. Through educational events, productive Tradeshows, and award-winning publications, the NACS is the gateway to securing new customers and growing your business in the $10 Billion campus market. The annual NACS Tradeshow attracts more than 22,000 industry stakeholders from around the world. Buyers and sellers come together to conduct business, learn from one another and network. The expo is segmented into six categories: Fuel Equipment & Services, Food Equipment & Foodservice Programs, Candy/Snacks, Facility Development & Store Operations, Merchandise and Technology. The Company intends to operate a Virtual Exhibitor Booth at the upcoming NACS Campus Market Expo Tradeshow (“NACS Tradeshow”) – February 22nd-26th, 2021. Recall that last year, February 10th-11th, 2020, the Company operated a main floor Exhibitor Booth (# 518) at the 2020 NACS Tradeshow – which took place at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
공시 • Jan 06Tauriga Sciences Inc. Completes the Translations of its Tauri-Gum Packaging into 4 Additional Languages: French, Arabic, Hebrew, and JapaneseTauriga Sciences, Inc. announced that it has completed the translated versions of its Tauri-Gum™ packaging into the following 4 additional languages: French, Arabic, Hebrew, and Japanese. The Company contracted GTS Translation Services (“GTS”) to provide this service, important to the Company’s long-term growth strategy. In particular, the Company is actively pursuing potential opportunities to launch its Tauri-Gum™ product line in the Middle East. The Company’s Tauri-Gum™ product line is both Kosher Certified (Authority: Star-K) and Halal Certified (Authority: Etimad). The Company’s international presence, via its E-Commerce customer base, continues to expand in terms of its customer base. Recently, the Company has received E-Commerce orders from: Israel, Kuwait, United Kingdom, and Australia. Previously, on December 21, 2020, the Company announced that it had successfully translated its Tauri-Gum™ packaging into Mandarin Chinese (“Mandarin”). At this time, the Company’s Tauri-Gum™ packaging is available in the following 6 languages: English, Mandarin Chinese, French, Arabic, Hebrew, and Japanese.
공시 • Dec 30Tauriga Sciences Inc. Expands Its CBD Infused Skin Care Offerings to Include More Than 10 Different ProductsTauriga Sciences, Inc. announced that its recently launched Skin Care Offerings have now been expanded to include more than 10 distinct CBD Infused products. These product offerings include CBD Infused: Face Moisturizer (100mg), Anti-Wrinkle Cream (30mg), Collagen/Tightening/Detoxifying Face Masks (4.20mg), Lip Balm (5mg), Hand & Foot Cream (N/A), Transdermal Patch (35mg), Massage & Body Oil (120mg), Body Spray (120mg), and Roll-On Product (240mg).
공시 • Dec 25Tauriga Sciences Inc. to Expand its Existing Product Line of CBD Infused Bath Bombs, Branded Under the Tauri-Gum NameTauriga Sciences, Inc. announced the planned expansion of its launched product line of Cannabidiol infused Bath Bombs – branded under Tauri-Gum. This planned expansion will include 2 distinct Cannabigerol infused Bath Bomb fragrances (Peach-Lemon & Black Currant) each will contain 100mg of CBG. There will also be a Pear Bellini Bath Bomb fragrance the formulation of which is still under development. On December 3, 2020, the Company disclosed the launch of 3 distinct CBD infused Bath Bomb fragrances: Blood Orange, Mint, and Pomegranate; each infused with 100mg of CBD and sold for $13.99 per Unit.
공시 • Dec 20Tauriga Sciences Inc. Enters into Master Services Agreement with Clinical Strategies & Tactics, Inc. to Resume the Clinical Development of Its Anti-Nausea Pharmaceutical Grade Version of Tauri-GumTauriga Sciences, Inc. announced that it has entered into a Master Services Agreement with North Carolina based Clinical Strategies & Tactics, Inc. to resume the clinical development of its proposed “Anti-Nausea” pharmaceutical grade version of Tauri-Gum™. CSTI will largely be focusing its efforts on the following: Pharmaceutical Development Strategy (“I.”), Commercialization Strategy (“II.”), and Funding Strategy (“III.”). The Company will be working closely with CSTI’s Founder & CEO, JoAnn C. Giannone (“Ms. Giannone”), who has over 25 years’ experience effectively leading companies through the drug and medical device development process (Prior to founding CSTI, Ms. Giannone held leadership positions with Johnson & Johnson and Pharmacia). The Company intends to fund the entirety of this Agreement, before the end of Calendar 2020.
공시 • Dec 18Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed “Anti-Nausea” Pharmaceutical Grade Version of Tauri-GumTauriga Sciences, Inc. announced the resumption of clinical development efforts, concerning its proposed “Anti-Nausea” pharmaceutical grade version of Tauri-Gum™. The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work). The delivery system for this proposed Pharmaceutical version is a modified version (substantially higher concentration of CBD) of the existing “Tauri-Gum™” chewing gum formulation based on continued research and development.
공시 • Dec 13Tauriga Sciences Inc. Commences Development of Vegan, CBD Infused Pet TreatTauriga Sciences, Inc. announced that it has commenced the development of a Vegan, Cannabidiol (“CBD”) infused Pet Food Treat (“Pet Treat”). The Company has contracted an industry expert to help with: formulations, specifications, designs, regulations, and certifications. The Company’s aim is to commercially launch its proposed Pet Treat product, during March 2021. Recall that on June 8, 2020, the Company issued the press release: “Tauriga Sciences Inc. Taking Concrete Steps to Expand into the Fast-Growing CBD Infused Pet Food Market Segment.” For the Year 2020, the U.S. pet treat market is projected at $7 Billion – driven by CBD & Other Ingredient trends.
공시 • Dec 10Tauriga Sciences, Inc. Announces New Product Offering to Help Ensure the Expansion and Diversification of its Proprietary Product OfferingsTauriga Sciences, Inc. ('Tauriga'or the 'Company') announced a new product offering to help ensure the expansion and diversification of the Company’s proprietary product offerings. This is in response to the Company’s fast growing E-Commerce business segment as well as the continually increasing customer base. After evaluating numerous potential new product offerings, the Company has decided to launch this CBD Infused Linden Honey (“CBD Honey”) product. This new product will be infused with 500mg of CBD per Jar (“Unit”) and each jar contains 20 servings (25mg CBD per serving). This product will also be Kosher Certified and of the highest quality. The Manufacturer’s Suggested Retail Price (“MSRP”) is expected to be set at USD 49.99 per Jar. This CBD Honey (16 oz. Jars) will be available exclusively on the Company’s E-Commerce Website. Raw Linden Honey is a tough honey to produce as the Linden trees are only in bloom 7-10 days annually. The honey has been described as having a very fresh aroma, described as: minty, menthol, camphor, balsamic, etc. Excellent honey for tea, desserts, muffins, hot cereal - you name it! The blooming season for Linden trees is generally the first week in July in the Northern Hemisphere.
공시 • Dec 04Tauriga Sciences, Inc. Introduces its Product Line of CBD Infused Bath Bombs Under the Tauri-Gum BrandTauriga Sciences, Inc. introduced its newest product line: CBD Infused Bath Bombs (Spherical Shape), under the Tauri-Gum™ brand. Over the past few weeks, the Company performed a Pilot Test – offering Blood Orange fragrance Bath Bombs – on its Shopify E-Commerce Platform (www.taurigum.com). All of the “Pilot Test” inventory was sold out and the customers reported positive reviews. This Bath Bomb product line is being launched with 3 distinct fragrances: Blood Orange, Mint, and Pomegranate. Each Bath Bomb is infused with 100mg of CBD isolate and will be sold for $13.99 per unit. This Bath Bomb product line is categorized as: CBD Infused Cosmetics.
공시 • Dec 03Tauriga Sciences Inc. to Commence Development of Caffeine Infused Version of Tauri-GumTauriga Sciences, Inc. announced that it has commenced development of a caffeine infused version of Tauri-Gum™. This new proposed product offering will contain 100mg of Caffeine in each piece of chewing gum; roughly equivalent to a standard 8oz cup of coffee. At this point, the Company believes that this product will incorporate the following all-natural Flavor(s); Cherry Cola. The anticipated Manufacturer’s Suggested Retail Price (MSRP): $8.99 per Blister Pack. The Company has decided to develop this 2nd Tauri-Gum™ SKU that does NOT contain any Phyto-Cannabinoids (Pear Bellini Flavor Tauri-Gum™ being the 1st SKU). This decision was partially in response to ongoing conversations with major retailers and other prospective future customers. Anticipated Launch Date: During January-February 2021 (4th Fiscal Quarter of 2021).
공시 • Nov 26Tauriga Sciences, Inc. Officially Transitions Its E-Commerce Payment Processing to Square Inc. & Is Now Approved to Accept American Express Credit CardsTauriga Sciences, Inc. announced the official transition of its E-Commerce payment processing to Square Inc. From now on, the Company’s E-Commerce platform no longer has type of individual transaction ($) limit imposed (previously it had been set at $3,000). The Company is also pleased to disclose that its E-Commerce website (www.taurigum.com) is now approved to accept American Express credit cards for online payments (previously this was limited to: Visa and Mastercard).
공시 • Nov 19Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New Covid-19 TestsAs previously announced, during April 2020, Tauriga Sciences, Inc. and Aegea Biotechnologies, Inc. have entered into a collaboration agreement to develop COVID-19 (novel coronavirus) assays. Aegea has made substantial progress in designing and developing two different, next generation assays for SARS-CoV-2. Aegea’s first new SARS-CoV-2 test under development is designed to have several advantages compared with other COVID-19 PCR assays as a result of the single nucleotide discrimination capacities of its patented Switch-Blocker technology. The assay is designed to detect low copy numbers of viral RNA, therefore potentially detecting the viral load at much lower levels than conventional PCR-based assays. If successful, this would be an important differentiating feature as it has been reported that asymptomatic patients are able to infect others. As designed, the COVID-19 PCR assay would also allow for superior specificity in its ability to identify the different strains of SARS-CoV-2, as well as distinguish SARS-CoV-2, which is associated with COVID-19, from other common forms of the SARS virus. Aegea’s second SARS-CoV-2 test under development also makes use of its patented technologies. This test will be performed on very simple, proprietary, affordable devices using saliva samples. Aegea’s second SARS-CoV-2 test is designed to be appropriate for testing at point-of-care and remote settings.
공시 • Nov 17Tauriga Sciences, Inc. Receives Its 4,000th E-Commerce OrderTauriga Sciences, Inc. announced that it has received its 4,000th online E-Commerce Order through its dedicated E-commerce website (www.taurigum.com). The Company continues to realize positive trends with respect to its highest margin E-Commerce business segment, such as: growing numbers of repeat customers, increase in average $amount per transaction, numerous testimonials, 5-Star product ratings, and continued robust sales of its Rainbow Pack.
공시 • Nov 07Tauriga Sciences, Inc. Experiencing Greater Market Acceptance for Its Cannabis (Cbd & Cbg) Infused Chewing Gum Product LineTauriga Sciences, Inc. announced that it is experiencing greater overall market acceptance for its Cannabis (“CBD” & “CBG”) infused chewing gum product line: Tauri-Gum™. This improved legal and regulatory landscape, as it pertains to CBD Edibles, has created important new opportunities for the Company. In recent days this has translated into strong levels of revenue growth as well as market acceptance. The Company is working with great determination to capitalize on this preferable business environment.
공시 • Oct 27Tauriga Sciences, Inc. to Commence 3rd Production Run of its CBD Infused Gum Drop Product – Branded As: Tauri-GummiesTauriga Sciences, Inc. announced plans to commence a 3rd production run of its Cannabidiol (“CBD”) infused Gum Drop product, branded as: Tauri-Gummies™. The company is incorporating a slight re-formulation for this 3rd production run, to improve this highly popular CBD edibles product. The company anticipates that this 3rd production run will be comprised of 3,000 – 5,000 Jars of Tauri-Gummies™. Each Jar contains 24 gum drops, with each gum drop infused with 25mg of CBD isolate (600mg CBD per Jar). The gum drops are manufactured in 4 distinct flavors: Cherry (Red), Orange (Orange), Lemon (Yellow), Lime (Green).
공시 • Oct 08Tauriga Sciences, Inc. Enters into Strategic Alliance with Think Big, LlcTauriga Sciences, Inc. announced that it has entered into a Strategic Alliance with Think Big, LLC. This new partnership includes a global licensing deal to bring co-branded CBD & CBG products to market.
공시 • Oct 07Tauriga Sciences, Inc. announced that it has received $0.135 million in fundingTauriga Sciences, Inc. (OTCPK:TAUG) announced that it has completed a private placement of a non-convertible promissory note for gross proceeds of $135,000 on October 6, 2020. The transaction included participation from an institutional investor. The note bears a fixed interest of 10% per annum, with a built in 6-month grace period. The note will be repaid in 7 equal monthly payments of $21,214.29 from April 5, 2021 through October 5, 2021.
공시 • Sep 30Tauriga Sciences Inc. Continues to Increase its National Network of DSD Distributors to Support Ongoing National Launch of its Brand Tauri-GumTauriga Sciences, Inc. announced the assembling of a national network of Direct Store Delivery Distributors in support of the ongoing national launch of its brand Tauri-Gum. Through its previously disclosed Agreement with Mr. Checkout Distributors, the company is continually increasing its network of DSD Distributors – which have the capability to place Tauri-Gum in many thousands of retail locations across the country. The company plans to issue future updates, as this national network continues to grow and strengthen. In other news, the company has entered into a major Joint Venture Partnership with a Los Angeles based firm. Full details of this important alliance and its positive attributes will be disclosed over the coming days.
공시 • Sep 29Tauriga Sciences, Inc. Becomes Vendor to Major Convenience Store & Gas Station Chain: Wawa, IncTauriga Sciences, Inc. announced that it has become a vendor to Wawa, Inc. The company has already presented its Tauri-Gum™ product line to the Wawa Purchasing Network. On Friday, September 25, 2020, the Company signed its Vendor Agreement with Wawa, Inc.
공시 • Sep 26Tauriga Sciences, Inc. Confirms Arrival of its Pear Bellini Flavor Tauri-Gum InventoryTauriga Sciences, Inc. announced the arrival of its Pear Bellini flavor Vitamin C & Zinc (“Immune Booster”) infused Tauri-Gum™ inventory – at its E-Commerce fulfillment center. This product is the Company’s only version of Tauri-Gum™ that contains NO Phyto-cannabinoids (i.e. CBD or CBG). Pear Bellini Tauri-Gum™ is now available on the Company’s E-Commerce website (www.taurigum.com). Each Blister Pack of Pear Bellini Tauri-Gum™ contains 480mg Vitamin C and 80mg Zinc -- Manufacturer’s Suggested Retail Price (“MSRP”): $12.99 per Blister Pack. The Company’s Pear Bellini Tauri-Gum™ is: Kosher Certified, Halal Certified, Vegan Formulated, NON-GMO, Allergen Free, Gluten Free, Contains NO Phytocannabinoids, Lab Tested, All-Natural Flavors, and 100% Made in the USA. In other news, the Company officially launched its highly anticipated Rainbow Deluxe Sampler Pack on September 20, 2020. The Company has been experiencing very strong levels of demand for its Rainbow Pack and is now shipping out many dozens of completed orders from its E-Commerce fulfillment facility.
공시 • Sep 18Tauriga Sciences, Inc. to Launch Rainbow Deluxe Sampler PackTauriga Sciences, Inc. announced that Rainbow Deluxe Sampler Pack will officially launch on September 20 on the Company’s E-Commerce platform. Pre-Orders for the Rainbow Pack have been robust, and the Company expects to announce a major partnership to enhance both the profile and scale of this launch.
공시 • Sep 17Tauriga Sciences, Inc. Showcases Final Design of Point of Sale Display Case for Select Retail LocationsTauriga Sciences, Inc. showcased the illustrative design of the Final version of its Point of Sale (“POS”) display case for select retail locations. This display case will be allocated to select, high volume, retail locations in support of upcoming National Roll-Out (“National Launch”) of Tauri-Gum™ brand (expected to commence during September 2020).
공시 • Jul 17Tauriga Sciences, Inc. announced that it has received $0.035 million in fundingTauriga Sciences, Inc. (OTCPK:TAUG) announced a private placement of 700,000 common shares at a price of $0.05 per share for gross proceeds of $35,000 on July 10, 2020. The transaction included participation from Chief Executive Officer of the company, Seth M. Shaw. The shares issued are restricted in nature.
